{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:16:29Z","timestamp":1783199789659,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.euo.2025.11.014","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:31:58Z","timestamp":1766129518000},"page":"581-588","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher Preoperative Maximum Standardised Uptake Values Are Associated with a Higher Risk of Metastases After Robot-assisted Radical Prostatectomy for Patients Undergoing 68Ga-PSMA-11 and 18F-DCFPyL Positron Emission Tomography\/Computed Tomography"],"prefix":"10.1016","volume":"9","author":[{"given":"K.C.C.","family":"de Bie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Creanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.J.L.","family":"Bodar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Donswijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.A.","family":"van Moorselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.E.","family":"Oprea-Lager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.N.","family":"Vis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.11.014_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euo.2025.11.014_b0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.11.014_b0015","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.11.014_b0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2021.05.016","article-title":"Overall survival of men with metachronous metastatic hormone-sensitive prostate cancer treated with enzalutamide and androgen deprivation therapy","volume":"80","author":"Sweeney","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.11.014_b0025","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.3390\/diagnostics13142343","article-title":"Higher preoperative maximum standardised uptake values (SUVmax) are associated with higher biochemical recurrence rates after robot-assisted radical prostatectomy for [68Ga]Ga-PSMA-11 and [18F]DCFPyL positron emission tomography\/computed tomography","volume":"13","author":"de Bie","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.euo.2025.11.014_b0030","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/bju.15710","article-title":"Standardised uptake values as determined on prostate-specific membrane antigen positron emission tomography\/computed tomography is associated with oncological outcomes in patients with prostate cancer","volume":"129","author":"Bodar","year":"2022","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.11.014_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13550-021-00818-2","article-title":"PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy","volume":"11","author":"Wang","year":"2021","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euo.2025.11.014_b0040","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00259-017-3631-6","article-title":"Ga-PSMA-11 PET\/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour","volume":"44","author":"Uprimny","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 3","key":"10.1016\/j.euo.2025.11.014_b0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bju.15762","article-title":"Event-free survival after radical prostatectomy according to prostate-specific membrane antigen-positron emission tomography and European Association of Urology biochemical recurrence risk groups","volume":"130","author":"Roberts","year":"2022","journal-title":"BJU Int"},{"issue":"Suppl 2","key":"10.1016\/j.euo.2025.11.014_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/bju.16482","article-title":"Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics","volume":"134","author":"Roberts","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.11.014_b0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13139-024-00884-z","article-title":"Exploring the correlation between multiparameters detected in primary prostate cancer using F\u201118 PSMA\u20111007 PET\/MRI and their potential for predicting metastasis","volume":"59","author":"Cheewadhanaraks","year":"2025","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.11.014_b0060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13550-021-00869-5","article-title":"Risk of metastatic disease using [F]PSMA-1007 PET\/CT for primary prostate cancer staging","volume":"11","author":"Chikatamarla","year":"2021","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euo.2025.11.014_b0065","article-title":"The 18F-PSMA-1007 PET\/CT performance on metastasis status and therapy assessment in oligo-metastasis prostate cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2025.11.014_b0070","article-title":"Predictive value of volumetric parameters based on F-PSMA-1007 PET\/CT for prostate cancer metastasis","volume":"14","author":"Li","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.euo.2025.11.014_b0075","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1007\/s00330-025-11360-3","article-title":"Baseline PSMA PET\/CT parameters predict overall survival and treatment response in metastatic castration-resistant prostate cancer patients","volume":"35","author":"Kleiburg","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2025.11.014_b0080","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s12094-024-03625-y","article-title":"PSMA PET\/CT SUVmax as a prognostic biomarker in patients with metachronous metastatic hormone-sensitive prostate cancer (mHSPC)","volume":"27","author":"Henr\u00edquez","year":"2025","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.euo.2025.11.014_b0085","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"EARL procedure for assessing PET\/CT system specific patient FDG activity preparations for quantitative FDG PET\/CT studies","volume":"42","author":"Boellaard","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.11.014_b0090","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1. 0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.11.014_b0095","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/cancers13071508","article-title":"Predicting the risk of metastases by PSMA-PET\/CT\u2014evaluation of 335 men with treatment-na\u00efve prostate carcinoma","volume":"13","author":"Koerber","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.euo.2025.11.014_b0100","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1007\/s00259-018-4037-9","article-title":"Ga-PSMA-617 PET\/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients","volume":"45","author":"Liu","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2025.11.014_b0105","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S1470-2045(24)00326-7","article-title":"Combining PSMA-PET and PROMISE to re-define disease stage and risk in patients with prostate cancer: a multicentre retrospective study","volume":"25","author":"Karpinski","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2025.11.014_b0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A systematic review of the factors affecting accuracy of SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.euo.2025.11.014_b0115","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.2967\/jnumed.117.192658","article-title":"F-DCFPyL PET\/CT in the detection of prostate cancer at 60 and 120 minutes: detection rate, image quality, activity kinetics, and biodistribution","volume":"58","author":"Wondergem","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2025.11.014_b0120","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1148\/radiol.220218","article-title":"18F-DCFPyL PET\/CT for initially diagnosed and biochemically recurrent prostate cancer: prospective trial with pathologic confirmation","volume":"305","author":"Ulaner","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.euo.2025.11.014_b0125","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2967\/jnumed.119.241174","article-title":"Factors predicting metastatic disease in 68Ga-PSMA-11 PET\u2013positive osseous lesions in prostate cancer","volume":"61","author":"Chiu","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2025.11.014_b0130","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.juro.2018.09.060","article-title":"Clinical usefulness of prostate and tumor volume related parameters following radical prostatectomy for localized prostate cancer","volume":"201","author":"Ito","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.11.014_b0135","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4274\/mirt.galenos.2019.63825","article-title":"Correlation of SUV(max) and apparent diffusion coefficient values detected by Ga-68 PSMA PET\/MRI in primary prostate lesions and their significance in lymph node metastasis: preliminary results of an on-going study","volume":"28","author":"Uslu-Be\u015fli","year":"2019","journal-title":"Mol Imaging Radionucl Ther"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125003244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125003244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:43:58Z","timestamp":1783197838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125003244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2588931125003244"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.11.014","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher Preoperative Maximum Standardised Uptake Values Are Associated with a Higher Risk of Metastases After Robot-assisted Radical Prostatectomy for Patients Undergoing 68Ga-PSMA-11 and 18F-DCFPyL Positron Emission Tomography\/Computed Tomography","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}